# First Busey Corp: financial statements, quarterly

BUSE · Nasdaq · CIK 314489 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/buse.md) · [Financials](/companies/buse/financials.md) · [Filings](/companies/buse/filings.md) · [Insiders](/companies/buse/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/buse/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | [111](/filings/0000314489-25-000191.md) | [116](/filings/0000314489-25-000284.md) | [118](/filings/0000314489-25-000314.md) | [117 d](/filings/0000314489-26-000013.md) | [125](/filings/0000314489-26-000033.md) | [198](/filings/0000314489-26-000055.md) | [196](/filings/0000314489-25-000314.md) | [200 d](/filings/0000314489-26-000013.md) | [196](/filings/0000314489-26-000033.md) | [197](/filings/0000314489-26-000055.md) |
| Interest expense | $m | [44.9](/filings/0000314489-23-000184.md) | [51.6 d](/filings/0000314489-24-000057.md) | [50.0](/filings/0000314489-24-000157.md) | [49.4](/filings/0000314489-24-000223.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [6.8](/filings/0000314489-24-000268.md) | [7.5 d](/filings/0000314489-26-000013.md) | [8.7](/filings/0000314489-25-000191.md) | [11.1](/filings/0000314489-25-000284.md) | [10.6](/filings/0000314489-25-000314.md) | [9.3 d](/filings/0000314489-26-000013.md) | [(2.7)](/filings/0000314489-26-000033.md) | [17.1](/filings/0000314489-26-000055.md) | [20.2](/filings/0000314489-25-000314.md) | [16.7 d](/filings/0000314489-26-000013.md) | [13.7](/filings/0000314489-26-000033.md) | [18.7](/filings/0000314489-26-000055.md) |
| Net income | $m | [30.7](/filings/0000314489-24-000268.md) | [25.7 d](/filings/0000314489-26-000013.md) | [26.2](/filings/0000314489-25-000191.md) | [27.4](/filings/0000314489-25-000284.md) | [32.0](/filings/0000314489-25-000314.md) | [28.1 d](/filings/0000314489-26-000013.md) | [(30.0)](/filings/0000314489-26-000033.md) | [47.4](/filings/0000314489-26-000055.md) | [57.1](/filings/0000314489-25-000314.md) | [60.8 d](/filings/0000314489-26-000013.md) | [50.0](/filings/0000314489-26-000033.md) | [63.2](/filings/0000314489-26-000055.md) |
| Diluted EPS | $ per share | [0.54](/filings/0000314489-24-000268.md) | not reported | [0.46](/filings/0000314489-25-000191.md) | [0.47](/filings/0000314489-25-000284.md) | [0.55](/filings/0000314489-25-000314.md) | not reported | [(0.44)](/filings/0000314489-26-000033.md) | [0.52](/filings/0000314489-26-000055.md) | [0.58](/filings/0000314489-25-000314.md) | not reported | [0.52](/filings/0000314489-26-000033.md) | [0.69](/filings/0000314489-26-000055.md) |
| Basic EPS | $ per share | [0.55](/filings/0000314489-24-000268.md) | not reported | [0.47](/filings/0000314489-25-000191.md) | [0.48](/filings/0000314489-25-000284.md) | [0.56](/filings/0000314489-25-000314.md) | not reported | [(0.44)](/filings/0000314489-26-000033.md) | [0.53](/filings/0000314489-26-000055.md) | [0.58](/filings/0000314489-25-000314.md) | not reported | [0.52](/filings/0000314489-26-000033.md) | [0.69](/filings/0000314489-26-000055.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | [0.7](/filings/0000314489-25-000041.md) | [0.6](/filings/0000314489-24-000157.md) | [0.3](/filings/0000314489-24-000223.md) | [0.6](/filings/0000314489-24-000268.md) | [0.7](/filings/0000314489-26-000013.md) | [1.2](/filings/0000314489-25-000191.md) | [0.8](/filings/0000314489-25-000284.md) | [0.4](/filings/0000314489-25-000314.md) | [0.3](/filings/0000314489-26-000055.md) | [0.3](/filings/0000314489-26-000033.md) | [0.7](/filings/0000314489-26-000055.md) |
| Total assets | $bn | [12.3](/filings/0000314489-23-000184.md) | [12.3](/filings/0000314489-25-000041.md) | [11.9](/filings/0000314489-24-000157.md) | [12.0](/filings/0000314489-24-000223.md) | [12.0](/filings/0000314489-24-000268.md) | [12.0](/filings/0000314489-26-000013.md) | [19.5](/filings/0000314489-25-000191.md) | [18.9](/filings/0000314489-25-000284.md) | [18.2](/filings/0000314489-25-000314.md) | [18.1](/filings/0000314489-26-000055.md) | [18.0](/filings/0000314489-26-000033.md) | [18.2](/filings/0000314489-26-000055.md) |
| Total liabilities | $bn | [11.1](/filings/0000314489-23-000184.md) | [11.0](/filings/0000314489-25-000041.md) | [10.6](/filings/0000314489-24-000157.md) | [10.6](/filings/0000314489-24-000223.md) | [10.6](/filings/0000314489-24-000268.md) | [10.7](/filings/0000314489-26-000013.md) | [17.3](/filings/0000314489-25-000191.md) | [16.5](/filings/0000314489-25-000284.md) | [15.7](/filings/0000314489-25-000314.md) | [15.6](/filings/0000314489-26-000055.md) | [15.6](/filings/0000314489-26-000033.md) | [15.8](/filings/0000314489-26-000055.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | [0.0](/filings/0000314489-23-000184.md) | [0.0](/filings/0000314489-24-000268.md) | [0.0](/filings/0000314489-24-000157.md) | [0.0](/filings/0000314489-24-000223.md) | [0.0](/filings/0000314489-24-000268.md) | [0.0](/filings/0000314489-26-000013.md) | [0.0](/filings/0000314489-25-000191.md) | [0.0](/filings/0000314489-25-000284.md) | [0.0](/filings/0000314489-25-000314.md) | [0.0](/filings/0000314489-26-000033.md) | [0.2](/filings/0000314489-26-000033.md) | not reported |
| Shareholders' equity | $bn | [1.2](/filings/0000314489-24-000268.md) | [1.3](/filings/0000314489-26-000013.md) | [1.3](/filings/0000314489-25-000284.md) | [1.3](/filings/0000314489-25-000314.md) | [1.4](/filings/0000314489-25-000314.md) | [1.4](/filings/0000314489-26-000055.md) | [2.2](/filings/0000314489-26-000055.md) | [2.4](/filings/0000314489-26-000055.md) | [2.4](/filings/0000314489-25-000314.md) | [2.5](/filings/0000314489-26-000055.md) | [2.4](/filings/0000314489-26-000055.md) | [2.4](/filings/0000314489-26-000055.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [42.2 d](/filings/0000314489-24-000268.md) | [46.1 d](/filings/0000314489-26-000013.md) | [37.4](/filings/0000314489-25-000191.md) | [28.5 d](/filings/0000314489-25-000284.md) | [60.1 d](/filings/0000314489-25-000314.md) | [52.3 d](/filings/0000314489-26-000013.md) | [8.4](/filings/0000314489-26-000033.md) | [49.5 d](/filings/0000314489-26-000055.md) | [62.5 d](/filings/0000314489-25-000314.md) | [72.2 d](/filings/0000314489-26-000013.md) | [51.5](/filings/0000314489-26-000033.md) | [41.5 d](/filings/0000314489-26-000055.md) |
| Capital expenditure | $m | [2.2 d](/filings/0000314489-24-000268.md) | [2.8 d](/filings/0000314489-26-000013.md) | [1.4](/filings/0000314489-25-000191.md) | [2.2 d](/filings/0000314489-25-000284.md) | [1.0 d](/filings/0000314489-25-000314.md) | [1.9 d](/filings/0000314489-26-000013.md) | [1.8](/filings/0000314489-26-000033.md) | [3.4 d](/filings/0000314489-26-000055.md) | [8.0 d](/filings/0000314489-25-000314.md) | [6.4 d](/filings/0000314489-26-000013.md) | [2.5](/filings/0000314489-26-000033.md) | [2.3 d](/filings/0000314489-26-000055.md) |
| Dividends paid | $m | [13.3 d](/filings/0000314489-24-000268.md) | [13.3 d](/filings/0000314489-26-000013.md) | [13.3](/filings/0000314489-25-000191.md) | [13.6 d](/filings/0000314489-25-000284.md) | [13.6 d](/filings/0000314489-25-000314.md) | [13.6 d](/filings/0000314489-26-000013.md) | [14.2](/filings/0000314489-26-000033.md) | [22.6 d](/filings/0000314489-26-000055.md) | [27.4 d](/filings/0000314489-25-000314.md) | [26.7 d](/filings/0000314489-26-000013.md) | [27.2](/filings/0000314489-26-000033.md) | [26.7 d](/filings/0000314489-26-000055.md) |
| Share repurchases | $m | [1.3 d](/filings/0000314489-24-000268.md) | [2.3 d](/filings/0000314489-26-000013.md) | [0.0](/filings/0000314489-25-000191.md) | [0.0 d](/filings/0000314489-25-000284.md) | [0.0 d](/filings/0000314489-25-000314.md) | [0.0 d](/filings/0000314489-26-000013.md) | [4.8](/filings/0000314489-26-000033.md) | [21.7 d](/filings/0000314489-26-000055.md) | [13.5 d](/filings/0000314489-25-000314.md) | [29.8 d](/filings/0000314489-26-000013.md) | [66.1](/filings/0000314489-26-000033.md) | [63.8 d](/filings/0000314489-26-000055.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [56.1](/filings/0000314489-23-000184.md) | [56.2](/filings/0000314489-24-000157.md) | [56.2](/filings/0000314489-24-000223.md) | [56.3](/filings/0000314489-24-000268.md) | [56.4](/filings/0000314489-25-000191.md) | [57.9](/filings/0000314489-25-000284.md) | [58.0](/filings/0000314489-25-000314.md) | [68.5](/filings/0000314489-26-000033.md) | [90.9](/filings/0000314489-26-000055.md) | [90.2](/filings/0000314489-25-000314.md) | [87.8](/filings/0000314489-26-000033.md) | [85.4](/filings/0000314489-26-000055.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 82,576,956 at 2026-08-06, from the cover of the [10-Q filed 2026-08-06](/filings/0000314489-26-000055.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.